Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia

@article{Kalin2013ComparisonOC,
  title={Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia},
  author={Gamze Kalin and Emine Alp and Ahmet Akin and Ramazan Coşkun and Melike Doğanay},
  journal={Infection},
  year={2013},
  volume={42},
  pages={37-42}
}
To compare clinical and microbiological efficacy of colistin and colistin/sulbactam for the treatment of multidrug-resistant (MDR) Acinetobacter baumannii VAP in intensive care units (ICUs). In this retrospective analysis, patients (>16 years-old) who received IV colistin or colistin/sulbactam for the treatment of MDR A. baumannii VAP were evaluated. The clinical and microbiological responses to therapies were assessed on the fifth day and at the end of the therapy. During the study period, 89… CONTINUE READING